Disease Management Archives - Page 17 of 24

The Importance Of Wellness In Mental Health Care – A Follow Up Interview With Saundra Jain, MA, PsyD, LPC

Interview April 6, 2018

During this follow up interview, Saundra Jain, MA, PsyD, LPC, further discusses the importance of including wellness alongside symptom reduction in treatment outcomes for patients with mental illness, as a… Read More

Q&A: Suicide Affects Everyone: The Role Of The Health Care Professional In Suicide Prevention

Podcast April 6, 2018

During this question and answer session, Christine Moutier, MD, and Anthony Pisani, PhD, responded to unanswered questions from their September 14, 2017 Virtual Forum entitled “Suicide Affects Everyone: The Role… Read More

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

Article March 28, 2018

Key Messages First-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) provided major therapeutic advances for idiopathic and non-idiopathic psychotic disorders, but long-term D2 receptor blockade by these medications can lead to… Read More

Five Years Of Specialised Early Intervention Versus Two Years Of Specialised Early Intervention Followed By Three Years Of Standard Treatment For Patients With A First Episode Psychosis: Randomised, Superiority, Parallel Group Trial In Denmark (OPUS II)

Article March 28, 2018

Key Messages Long-term follow-up studies of specialized early intervention (SEI) programs following discontinuation have been contradictory. OPUS II was the first prolonged SEI study beyond three years. OPUS II reported… Read More

STEP-BD Hypotheses, Findings, & Clinical Implications With Dr. Joseph Goldberg

Interview March 7, 2018

In this interview, Jehan Marino, PharmD, BCPP, Senior Medical Science Liasion for Otsuka Pharmaceutical Development & Commercialization, Inc., speaks with Joseph Goldberg, MD, PsychU Bipolar Disorder Section Editor, Clinical Professor… Read More

Long-Acting Injectable Adherence & Sociodemographic Characteristics Of Use

Video February 14, 2018

In this interview, James McCreath, PhD, Vice President of Psychiatry & Behavioral Health at the Trinitas Regional Medical Center, discusses his co-authored publication “Long-Acting Injectable Antipsychotics For Schizophrenia: Sociodemographic Characteristics… Read More

Disease Management

The Importance Of Wellness In Mental Health Care – A Follow Up Interview With Saundra Jain, MA, PsyD, LPC

Q&A: Suicide Affects Everyone: The Role Of The Health Care Professional In Suicide Prevention

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

Five Years Of Specialised Early Intervention Versus Two Years Of Specialised Early Intervention Followed By Three Years Of Standard Treatment For Patients With A First Episode Psychosis: Randomised, Superiority, Parallel Group Trial In Denmark (OPUS II)

STEP-BD Hypotheses, Findings, & Clinical Implications With Dr. Joseph Goldberg

Long-Acting Injectable Adherence & Sociodemographic Characteristics Of Use

Systematic Treatment Enhancement Program For Bipolar Disorder (STEP-BD): An Introduction To The Initial Findings

Burnout & Satisfaction With Work-Life Balance Among US Physicians Relative To The General US Population

Tools To Assess & Address Medication Adherence In Patients With Serious Mental Illness

Mental Health & Metabolic Wellness Series: Focus On Hypertension

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: